GFACX
Price
$56.51
Change
-$2.32 (-3.94%)
Updated
Apr 10 closing price
Net Assets
271.59B
LGLRX
Price
$37.62
Change
-$1.66 (-4.23%)
Updated
Apr 10 closing price
Net Assets
5.97B
Ad is loading...

GFACX vs LGLRX

Header iconGFACX vs LGLRX Comparison
Open Charts GFACX vs LGLRXBanner chart's image
American Funds Growth Fund of Amer C
Price$56.51
Change-$2.32 (-3.94%)
VolumeN/A
Net Assets271.59B
Lord Abbett Growth Leaders R3
Price$37.62
Change-$1.66 (-4.23%)
VolumeN/A
Net Assets5.97B
GFACX vs LGLRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. LGLRX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and LGLRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 272B vs. LGLRX (5.97B). GFACX (0.00) and LGLRX (0.00) have matching dividends . GFACX was incepted earlier than LGLRX: GFACX (24 years) vs LGLRX (14 years). GFACX (1.36) is less costly to investors than LGLRX (1.16). LGLRX is a more actively managed with annual turnover of: 94.00 vs. GFACX (25.00). LGLRX has a lower initial minimum investment than GFACX: LGLRX (0) vs GFACX (250). LGLRX annual gain was more profitable for investors over the last year : 7.03 vs. GFACX (-3.95). LGLRX return over 5 years is better than : 49.58 vs. GFACX (40.74).
GFACXLGLRXGFACX / LGLRX
Total Expense Ratio1.361.16117%
Annual Report Gross Expense Ratio1.361.16117%
Fund Existence24 years14 years-
Gain YTD-7.732-13.30858%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets272B5.97B4,555%
Annual Yield % from dividends0.000.00-
Returns for 1 year-3.957.03-56%
Returns for 3 years4.3523.6018%
Returns for 5 years40.7449.5882%
Returns for 10 years38.8268.4457%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DGLY0.03N/A
+15.27%
Digital Ally
BDSX0.570.02
+4.51%
Biodesix
TAP59.951.44
+2.46%
Molson Coors Beverage Company
GYRE7.29-0.51
-6.54%
Gyre Therapeutics
GDRX4.32-0.37
-7.89%
GoodRx Holdings